Jui‐I Chao

2.8k total citations
49 papers, 2.3k citations indexed

About

Jui‐I Chao is a scholar working on Oncology, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Jui‐I Chao has authored 49 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Materials Chemistry. Recurrent topics in Jui‐I Chao's work include Diamond and Carbon-based Materials Research (12 papers), Cancer-related Molecular Pathways (11 papers) and Microtubule and mitosis dynamics (6 papers). Jui‐I Chao is often cited by papers focused on Diamond and Carbon-based Materials Research (12 papers), Cancer-related Molecular Pathways (11 papers) and Microtubule and mitosis dynamics (6 papers). Jui‐I Chao collaborates with scholars based in Taiwan, United States and Czechia. Jui‐I Chao's co-authors include Kuang‐Kai Liu, Huei-Fang Liu, Chia‐Ching Chang, Huan‐Cheng Chang, Chinpiao Chen, Jia‐Ling Yang, Cheng-Hsiang Hsiao, Johnson Lin, Chia‐Liang Cheng and Ted H. Chiu and has published in prestigious journals such as Journal of Biological Chemistry, Applied Physics Letters and Biomaterials.

In The Last Decade

Jui‐I Chao

49 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jui‐I Chao Taiwan 23 895 795 527 347 329 49 2.3k
Xinghua Wang China 35 1.3k 1.5× 1.4k 1.8× 624 1.2× 215 0.6× 274 0.8× 147 3.6k
Yanan Liu China 30 376 0.4× 1.2k 1.6× 249 0.5× 322 0.9× 506 1.5× 131 2.8k
Benoît Paquette Canada 27 359 0.4× 551 0.7× 401 0.8× 233 0.7× 386 1.2× 85 1.9k
Jingwen Xu China 31 229 0.3× 1.4k 1.8× 249 0.5× 495 1.4× 360 1.1× 181 3.4k
D. K. Srivastava United States 31 438 0.5× 1.6k 2.0× 375 0.7× 141 0.4× 236 0.7× 123 2.8k
Yue Wu China 33 1.5k 1.7× 1.1k 1.4× 295 0.6× 236 0.7× 423 1.3× 174 4.0k
Alexandr A. Kapralov United States 33 1.2k 1.4× 3.0k 3.8× 1.2k 2.2× 425 1.2× 202 0.6× 67 5.4k
Chen Xiao China 32 740 0.8× 1.2k 1.5× 1.5k 2.8× 457 1.3× 336 1.0× 81 3.2k
Nian Wu United States 30 584 0.7× 1.0k 1.3× 478 0.9× 85 0.2× 384 1.2× 70 2.8k
Iseli L. Nantes Brazil 25 346 0.4× 1.0k 1.3× 198 0.4× 170 0.5× 146 0.4× 120 2.0k

Countries citing papers authored by Jui‐I Chao

Since Specialization
Citations

This map shows the geographic impact of Jui‐I Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui‐I Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui‐I Chao more than expected).

Fields of papers citing papers by Jui‐I Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui‐I Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui‐I Chao. The network helps show where Jui‐I Chao may publish in the future.

Co-authorship network of co-authors of Jui‐I Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Jui‐I Chao. A scholar is included among the top collaborators of Jui‐I Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui‐I Chao. Jui‐I Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhiqin, Yuan-Chin Hsieh, I‐Ju Chen, et al.. (2023). A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis. Inflammation and Regeneration. 43(1). 13–13. 5 indexed citations
2.
Chen, Chien‐Hung, Chih‐Man Yang, Ming‐Chang Tsai, et al.. (2022). Co-inhibition of Aurora A and Haspin kinases enhances survivin blockage and p53 induction for mitotic catastrophe and apoptosis in human colorectal cancer. Biochemical Pharmacology. 206. 115289–115289. 6 indexed citations
3.
Liu, Kuang‐Kai, et al.. (2017). Synthesis and biological assay of erlotinib analogues and BSA-conjugated erlotinib analogue. Bioorganic & Medicinal Chemistry Letters. 27(8). 1784–1788. 10 indexed citations
4.
Lin, Johnson, et al.. (2014). The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer. Chemico-Biological Interactions. 220. 41–50. 18 indexed citations
5.
Liu, Kuang‐Kai, et al.. (2014). Labeling of neuronal differentiation and neuron cells with biocompatible fluorescent nanodiamonds. Scientific Reports. 4(1). 5004–5004. 63 indexed citations
6.
Chao, Jui‐I, et al.. (2014). Optimization of gefitinib analogues with potent anticancer activity. Bioorganic & Medicinal Chemistry Letters. 24(22). 5247–5250. 18 indexed citations
7.
Liu, Kuang‐Kai, et al.. (2014). The effect of fluorescent nanodiamonds on neuronal survival and morphogenesis. Scientific Reports. 4(1). 6919–6919. 56 indexed citations
8.
Vankayala, Raviraj, et al.. (2014). A general strategy to achieve ultra-high gene transfection efficiency using lipid-nanoparticle composites. Biomaterials. 35(28). 8261–8272. 15 indexed citations
9.
Liu, Kuang‐Kai, et al.. (2012). The long-term stability and biocompatibility of fluorescent nanodiamond as an in vivo contrast agent. Biomaterials. 33(31). 7794–7802. 204 indexed citations
10.
Liu, Huei-Fang, et al.. (2010). Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells. Chemico-Biological Interactions. 188(3). 535–545. 28 indexed citations
11.
Liu, Kuang‐Kai, et al.. (2009). Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. Biomaterials. 30(26). 4249–4259. 190 indexed citations
12.
Liu, Kuang‐Kai, Mei-Fang Chen, Tony J.-F. Lee, et al.. (2008). Alpha-bungarotoxin binding to target cell in a developing visual system by carboxylated nanodiamond. Nanotechnology. 19(20). 205102–205102. 47 indexed citations
13.
Chang, Chia‐Ching, et al.. (2007). Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells. Toxicology and Applied Pharmacology. 222(1). 97–104. 42 indexed citations
14.
Liu, Kuang‐Kai, et al.. (2007). Biocompatible and detectable carboxylated nanodiamond on human cell. Nanotechnology. 18(32). 325102–325102. 236 indexed citations
15.
Chiu, Shu-Jun, Tzu-Sheng Hsu, & Jui‐I Chao. (2007). Expression of securin promotes colorectal cancer cell death via a p53-independent pathway after radiation. Chemico-Biological Interactions. 170(3). 153–161. 2 indexed citations
16.
Chiu, Shu‐Jun, Tzu-Sheng Hsu, & Jui‐I Chao. (2006). Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells. Toxicology Letters. 167(2). 122–130. 22 indexed citations
17.
Lin, Johnson, et al.. (2005). Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells. Biochemical Pharmacology. 70(5). 658–667. 65 indexed citations
18.
Tsou, Tsui‐Chun, et al.. (2005). Inhibition of α7-nicotinic acetylcholine receptor expression by arsenite in the vascular endothelial cells. Toxicology Letters. 159(1). 47–59. 7 indexed citations
19.
Chao, Jui‐I & Huei-Fang Liu. (2005). The Blockage of Survivin and Securin Expression Increases the Cytochalasin B-Induced Cell Death and Growth Inhibition in Human Cancer Cells. Molecular Pharmacology. 69(1). 154–164. 28 indexed citations
20.
Chao, Jui‐I, et al.. (2005). Depletion of Securin Increases Arsenite-Induced Chromosome Instability and Apoptosis via a p53-Independent Pathway. Toxicological Sciences. 90(1). 73–86. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinghua Wang Breakdown of academic impact, for papers by Yanan Liu Breakdown of academic impact, for papers by Benoît Paquette Breakdown of academic impact, for papers by Jingwen Xu Breakdown of academic impact, for papers by D. K. Srivastava Breakdown of academic impact, for papers by Yue Wu Breakdown of academic impact, for papers by Alexandr A. Kapralov Breakdown of academic impact, for papers by Chen Xiao Breakdown of academic impact, for papers by Nian Wu Breakdown of academic impact, for papers by Iseli L. Nantes
Rankless by CCL
2026